Vaccine News and Research

Latest Vaccine News and Research

Study finds vaccine distrust among majority of incarcerated people

Fewer than half of inmates in jails and prisons surveyed in a study by the CDC and University of Washington said they would accept a COVID-19 vaccine, while the majority either said they wanted to wait before getting the vaccine or would refuse one.

1 Apr 2021

COVID-19: Several 'proxy wars' spawned by the pandemic

When Australia, India, Japan and the US — countries strategically allied under the so-called Quad (Quadrilateral Security Dialogue) — switched focus to fighting COVID-19, it was seen as one more of the several 'proxy wars' spawned by the pandemic.

1 Apr 2021

KHN’s ‘What the Health?’: Planning for round two

Congress is out of session, but that hasn't stopped Democrats from planning their next round of health legislation.

1 Apr 2021

Study discovers new target on SARS-CoV-2 spike for protective antibodies

Researchers at The Scripps Research Institute, USA, have described a potential target for COVID-19 vaccines. Dubbed as CC40.8 bnAb, it exhibited broad reactivity with human beta coronaviruses.

1 Apr 2021

Can asymptomatic COVID-19 confer long-term immunity?

Researchers examined the antibody responses in symptomatic and asymptomatic individuals recovered from COVID-19 to see if there was a discernable difference in their humoral immune responses and long-term protection from reinfection with SARS-CoV-2.

1 Apr 2021

Could a flavonoid found in common fruit and vegetables combat COVID-19?

Researchers in India have gathered and presented a large body of evidence highlight quercetin – a flavonoid molecule found in many common fruits and vegetables – may be developed into drug therapies used to combat COVID-19.

1 Apr 2021

Researchers develop a recombinant SARS-CoV-2 receptor-binding domain trimer vaccine candidate

New research deals with the development of RBD trimer as a potent target for SARS-CoV-2 subunit vaccines. This study revealed the development of a trimeric RBD subunit vaccine candidate that could induce strong humoral and cellular immune responses in nonhuman primates (NHPs), namely, rhesus macaques.

1 Apr 2021

Study investigates U.S. public support for COVID-19 vaccine donation to less prosperous countries

The pandemic is affecting every country, but not every country has equal access to the lifesaving COVID-19 vaccines. Recent estimates show that high-income countries -- which have just one-fifth of the global adult population -- have purchased more than half of the world's total vaccine doses, resulting in disparities for low- and middle-income countries.

1 Apr 2021

COVID-19 vaccine acceptance in pregnancy

A new preprint research paper posted to the medRxiv* server shows that while pregnant women are seriously worried about their risk of contracting the infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but are also hesitant to take the vaccine.

1 Apr 2021

Antibodies produced from infection with SARS-CoV-2 501Y.V2 protect against other variants

A recent paper in the journal Nature shows that while earlier lineages do not elicit antibodies capable of efficiently neutralizing the newly emerged South African variant, SARS-CoV-2 501Y.V2 (B.1.351), the converse does occur.

31 Mar 2021

Oxford-AstraZeneca vaccine effective against B.1.1.7 SARS-CoV-2 variant

Published in The Lancet, the study explores if the Oxford-AstraZeneca vaccine works well in protecting against the B.1.1.7 variant, otherwise known as the U.K. variant.

31 Mar 2021

Risk of SARS-CoV-2 from reinfected individuals with previous infection or vaccination

A technical report recently published by the European Center for Disease Prevention and Control (ECDC) has summarized all available literature regarding the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission from asymptomatic reinfected individuals with a history of SARS-CoV-2 infection or vaccination.

31 Mar 2021

New Phase 1 clinical trial of investigational vaccine against B.1.351 SARS-CoV-2 variant begins

An investigational vaccine designed to protect against the B.1.351 SARS-CoV-2 variant has been administered as part of a new Phase 1 clinical trial evaluating the vaccine candidate's safety and immunogenicity in adult volunteers.

31 Mar 2021

2021 AGS Annual Scientific Meeting goes virtual for the first time

The worlds of work, education, and networking have changed drastically in the past year, and the American Geriatrics Society is evolving with them.

31 Mar 2021

Tamper-proof temperature indicator could help monitor ideal storage conditions of mRNA vaccines

Scientists have developed vaccines for COVID-19 with record speed. The first two vaccines widely distributed in the U.S. are mRNA-based and require ultracold storage (-70 C for one and -20 C for the other).

31 Mar 2021

New mRNA COVID-19 vaccine candidate shows promise in vivo

Researchers report that a new lipid nanoparticle mRNA coronavirus disease 2019 (COVID-19) vaccine candidate protected 70% of mice expressing the human angiotensin-converting enzyme 2 (ACE2), while all the non-vaccinated mice died.

31 Mar 2021

Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay

A team of researchers recently discussed the potential role of a new assay in bridging a major gap in SARS-CoV-2 research. This assay can throw light on 1) the selection of complementary monoclonal antibody candidates and 2) rapid identification of the immune escape to emerging RBD variants following vaccination or natural infection.

31 Mar 2021

Vaccine News and Research

Latest Vaccine News and Research

Study finds vaccine distrust among majority of incarcerated people

COVID-19: Several 'proxy wars' spawned by the pandemic

KHN’s ‘What the Health?’: Planning for round two

Study discovers new target on SARS-CoV-2 spike for protective antibodies

Can asymptomatic COVID-19 confer long-term immunity?

Could a flavonoid found in common fruit and vegetables combat COVID-19?

Researchers develop a recombinant SARS-CoV-2 receptor-binding domain trimer vaccine candidate

Study investigates U.S. public support for COVID-19 vaccine donation to less prosperous countries

COVID-19 vaccine acceptance in pregnancy

Antibodies produced from infection with SARS-CoV-2 501Y.V2 protect against other variants

Oxford-AstraZeneca vaccine effective against B.1.1.7 SARS-CoV-2 variant

Risk of SARS-CoV-2 from reinfected individuals with previous infection or vaccination

New Phase 1 clinical trial of investigational vaccine against B.1.351 SARS-CoV-2 variant begins

2021 AGS Annual Scientific Meeting goes virtual for the first time

Tamper-proof temperature indicator could help monitor ideal storage conditions of mRNA vaccines

New mRNA COVID-19 vaccine candidate shows promise in vivo

Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay

Infliximab may hinder the effectiveness of some COVID-19 vaccines

Asymmetrical vaccine distribution could promote vaccine evading mutations in SARS-CoV-2

mRNA COVID-19 vaccines are highly effective among front liners, CDC study shows

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in